SynthesisPloS one2014

Efficacy and safety of dipeptidyl peptidase-4 inhibitors in type 2 diabetes mellitus patients with moderate to severe renal impairment: a systematic review and meta-analysis.

Dongsheng Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.